elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-FE66B7D9-C5AD-4EEF-96FA-1949209CD17C
Q27852097-FE66B7D9-C5AD-4EEF-96FA-1949209CD17C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-FE66B7D9-C5AD-4EEF-96FA-1949209CD17C
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P698
Q27852097-FE66B7D9-C5AD-4EEF-96FA-1949209CD17C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-FE66B7D9-C5AD-4EEF-96FA-1949209CD17C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ffe13d978725b57423664a95597302c6f13ea51
P698
23434733
http://www.w3.org/2001/XMLSchema#string